LHCVX Mutual Fund (Lord Abbett Health Care Fund Class R6) is managed by Lord Abbett Family of Funds. LHCVX expense ratio is 0.68%, holding 64 positions across sectors including Health Care, Unknown, Other. Inception date: 2019-07-31.

LHCVX performance shows a YTD return of 4.77%. The 1-year return is 27.76% and the 5-year return is 6.02%. LHCVX dividend yield stands at 0.35%, paid annually.

LHCVX top holdings include Eli Lilly & Co (8.9%), AstraZeneca PLC (4.7%), Gilead Sciences Inc (4.3%), Johnson & Johnson (3.2%), Nektar Therapeutics (3.2%). View all LHCVX holdings, sector breakdown, or dividend history.

LHCVX can be compared against other funds using the overlap calculator or side-by-side comparison tool. LHCVX alternatives are available via the screener, along with tax-loss harvesting opportunities.